ClinicalTrials.Veeva

Menu

Virtual Reality as a New Therapeutic Tool for Chronic Pain

I

Insel Gruppe AG, University Hospital Bern

Status

Withdrawn

Conditions

Fibromyalgia

Treatments

Device: Virtual reality control
Other: Standard therapy
Device: Virtual reality heart

Study type

Interventional

Funder types

Other

Identifiers

NCT04108702
2019-01515

Details and patient eligibility

About

Chronic pain is a major health problem and it has been estimate to account for approximately 40% of all medical visits, costing more than $600 billion annually in the United States alone. Given that pharmacological and non-pharmacological treatments for chronic pain are often difficult and may be associated with limiting side effects, technology-based interventions using virtual reality (VR) may be a promising alternative treatment option. Recent findings from cognitive neuroscience show that it is possible to manipulate the body schema and to induce a range of well-controlled illusory bodily experiences by exposing participants to conflicting multisensory bodily inputs using VR, that are associated with changes in pain perception and somatosensory processing in healthy subjects and chronic pain patients. In the current project the investigators plan to follow up on these findings in patients suffering from chronic pain affecting the whole body, e.g. fibromyalgia. The project is planned as a single center clinical study at the Department of Neurology and Psychosomatic Medicine, Inselspital Bern, in cooperation with the Pain Center Inselspital Bern, the Department of Biomedical Engineering; University Bern and the Department of Psychology, University of Bern. The investigators want to explore the analgesic effect of a specific multisensory illusion (e.g. the cardio-visual illusion) in patients suffering from chronic pain as compared to a control condition (single-blinded, randomized clinical trial) using psychometric and algometric methods. Moreover, the investigators would like to assess the physiological changes associated with pain reduction, study the reduction of psychological distress and improved well-being and assess the subjective acceptance of VR as a possible treatment option for patients with chronic pain. Importantly, the investigators plan to develop and test an easy to use, mobile VR setup as a long-term treatment option for patients with chronic pain. Given that chronic pain is a major health problem, the investigators believe that there is a huge market potential for an easy to use, noninvasive and effective treatment option and a possible technology transfer.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria

  • A diagnosis of fibromyalgia according to current diagnostic criteria
  • Aged > 18 years old
  • Capable of judgement
  • Willing to participate in the study (by signing the informed consent form)
  • Able to follow the study protocol

Exclusion criteria

  • Presence of psychosis or major depression with suicidal risk
  • History of alcohol or drug abuse
  • Inability to follow the procedures of the study, e.g. due to language problems, inability to wear head-mounted display
  • Arrythmia, such as atrial fibrillation

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

0 participants in 3 patient groups

VR heart
Experimental group
Treatment:
Other: Standard therapy
Device: Virtual reality heart
VR control
Sham Comparator group
Treatment:
Device: Virtual reality control
Other: Standard therapy
Standard control
Active Comparator group
Treatment:
Other: Standard therapy

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems